Treatment for problematic sexual behavior in preteen children
Treatment for Problematic Sexual Behavior of Preteen Children
This study is testing a new treatment for preteen children with problematic sexual behavior to see if it works better than the usual methods.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 42 (estimated) |
| Ages | 4 Years to 12 Years |
| Sex | All |
| Sponsor | Milton S. Hershey Medical Center Academic / other |
| Locations | 1 site (Harrisburg, Pennsylvania) |
| Trial ID | NCT05514730 on ClinicalTrials.gov |
What this trial studies
This clinical trial investigates a new intervention called Phase-Based Treatment (PBT) for addressing problematic sexual behavior (PSB) in preteen children. The study aims to compare the effectiveness of PBT against standard treatment approaches through a randomized controlled trial (RCT). Previous pilot studies have shown promising results, indicating that PBT may lead to significant improvements in managing PSB. The trial will also assess feasibility, participant satisfaction, and recruitment strategies for future larger-scale studies.
Who should consider this trial
Good fit: Ideal candidates for this study are children aged 4 to 12 years who exhibit problematic sexual behavior and have a caregiver willing to participate in the treatment.
Not a fit: Patients who may not benefit from this study include those whose caregivers report lower levels of problematic behavior or who are suspected of perpetrating child sexual abuse.
Why it matters
Potential benefit: If successful, this treatment could provide a more effective intervention for managing problematic sexual behavior in preteen children, leading to better outcomes for affected families.
How similar studies have performed: While previous studies have shown positive outcomes with similar interventions, this RCT represents a novel approach to rigorously evaluate the effectiveness of PBT.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Child between ages 4 and 12 years * Caregiver reports a raw score on the CSBI greater than 4. * A primary caregiver is willing to participate in treatment. * Child earns a scaled score above 69 on the Kaufman Brief Intelligence Test (KBIT-2) * Child proficient in spoken English * Caregiver proficient in written and spoken English. Exclusion Criteria: * Child is less than 4 years of age or older than 12 years of age. * Caregiver reports a score on the CSBI lower than 4 * A primary caregiver is unwilling to participate in treatment. * Child scored lower than 70 on the KBIT-2. * The primary caregiver is suspected of perpetrating child sexual abuse. * Child not proficient in spoken English. * Caregiver not proficient in both written and spoken English.
Where this trial is running
Harrisburg, Pennsylvania
- Penn State Hershey Medical Center-TLC Research and Treatment Center — Harrisburg, Pennsylvania, United States (Recruiting)
Study contacts
- Study coordinator: Brian Allen, PsyD
- Email: ballen1@pennstatehealth.psu.edu
- Phone: 7175314100
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.